- Protein Name
- Receptor tyrosine-protein kinase erbB-2
- Gene Name
- ERBB2
- Organism
-
Homo sapiens
- Function
- Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization.
In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth.
Site |
Maximum Consensus Site Population |
Minimum Consensus Site Population |
Median Consensus Site Population |
MPP |
15 |
2 |
5.0 |
DFG |
17 |
17 |
17.0 |
PIF |
13 |
12 |
12.0 |
DRS |
17 |
9 |
13.5 |
EDI |
5 |
3 |
4.0 |
MT3 |
22 |
2 |
9.0 |
PDIG |
6 |
3 |
5.0 |
ATP |
16 |
3 |
15.0 |
PDB ID |
Maximum Consensus Site Population |
MPP site |
DFG site |
PIF site |
DRS site |
DEF site |
EDI site |
MT3 site |
AAS site |
LBP site |
CMP site |
PDIG site |
ATP site |
PMP site |
Total Druggable Structures per Site |
0 |
1 |
0 |
1 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
1 |
0 |
AFP04626
|
0 |
17 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3PP0
|
15 |
0 |
0 |
0 |
0 |
5 |
22 |
0 |
0 |
0 |
6 |
14 |
0 |
3RCD
|
11 |
0 |
13 |
17 |
0 |
3 |
17 |
0 |
0 |
0 |
5 |
16 |
0 |